REP has received consulting fees from Bayer, Corcept Therapeutics, Dexcom, Hanmi Pharmaceutical, Merck, Novo Nordisk, Pfizer, Sanofi, Scohia Pharma and Sun Pharmaceutical Industries, and grants/research support from Hanmi Pharmaceutical, Janssen, Metavention, Novo Nordisk, Poxel and Sanofi
Potential as a Stand-Alone or Combination Therapy Because this drug operates through a mechanism distinct from GLP-1 medications, it may be effective on its own or when paired with GLP-1 drugs
As a result, all the inflammation-related parameters were significantly increased in HFD group, proving the occurrence of inflammatory response
It prevents or reverses acne, wrinkles and crows feet via detoxification of the skin and body